Vetsys Pharmaceutical
Vetsys Pharmaceutical
The global dairy industry faces a persistent challenge: Bovine Mastitis. As one of the most significant diseases affecting dairy cattle worldwide, it causes billions of dollars in annual losses due to reduced milk yield, discarded milk, and premature culling. Intramammary treatments have emerged as the gold standard for both therapeutic and prophylactic management of udder health. In the modern industrial livestock era, the demand for high-efficacy infusions containing Cefquinome Sulfate, Ampicillin, and Cloxacillin has skyrocketed, particularly in regions like North America, Europe, and the rapidly expanding dairy markets of Asia.
From a commercial perspective, intramammary infusions are no longer just "farm supplies"—they are high-tech pharmaceutical formulations requiring precise viscosity, sterile delivery systems (syringes), and targeted antibiotic release. Global procurement managers now prioritize suppliers who can offer GMP-certified manufacturing and long-lasting infection protection. As a leading hub for veterinary pharmaceutical production, China has become a critical node in the global supply chain, offering a balance of innovation, scale, and cost-efficiency.
Shift towards narrow-spectrum antibiotics to combat AMR (Antimicrobial Resistance) and a growing focus on "Dry Cow Therapy" to prevent new infections during the non-lactating period.
Enterprises require localized application support, reliable withdrawal period data, and multi-use wound care options that comply with international safety standards.
Preference for 4th generation cephalosporins like Cefquinome due to their high distribution in udder tissue and resistance to beta-lactamases.
Established Year
Registered Capital (RMB)
Annual Sales
Specialized Labs
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health.
Our research focuses on the molecular pharmacology of Intramammary Infusions, ensuring that active ingredients like Cefquinome Sulfate reach therapeutic concentrations quickly and maintain them throughout the treatment cycle. By utilizing advanced drug delivery systems, we reduce animal stress and improve the recovery rates of lactating cows.
Whether it's the high-altitude dairy farms in Latin America or the intensive feedlots in the Middle East, our treatments are designed for diverse climate conditions and localized bacterial strains.
Our ampicillin and cloxacillin formulations provide a critical barrier during the dry period, ensuring the cow's udder is healthy and ready for the next lactation cycle.
As a seasoned exporter, Vetsys provides comprehensive documentation (COA, GMP certificates) and customized packaging to meet the regulatory requirements of different nations.
Quality is the cornerstone of our operations, and Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market.
Vetsys believes that excellence in product quality is essential to long-term growth and sustainability. Our focus on quality management allows us to maintain trust and loyalty among our customers, setting us apart as a reliable partner in animal healthcare. From Extrusion Molding to final Drying and Packing, every step is scrutinized by our AI-enhanced monitoring systems.
As part of our long-term vision, Vetsys is also committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize the impact of our operations on the environment. Our products are not only designed for efficacy but also to promote the overall well-being of both animals and the environment.
In addition to our strong presence in the domestic market, Vetsys is actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets. Our future strategy includes partnerships, research collaborations, and expanding our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare.
